Curran, D. Et Al. 2018. Impact of a recombinant zoster vaccine on quality of life: data from a randomized, placebo controlled phase 3 trial in adult hematopoietic stem cell transplant recipients. IDWeek , (California, United States Of America), 744.

Curran, D., Anagnostopoulos, A., Barışta, İ., Bastıdas, A., Chandrasekar, P., Dıckınson, M., ... Heras, I.(2018). Impact of a recombinant zoster vaccine on quality of life: data from a randomized, placebo controlled phase 3 trial in adult hematopoietic stem cell transplant recipients . IDWeek (pp.744). California, United States Of America

Curran, D Et Al. "Impact of a recombinant zoster vaccine on quality of life: data from a randomized, placebo controlled phase 3 trial in adult hematopoietic stem cell transplant recipients," IDWeek, California, United States Of America, 2018

Curran, D Et Al. "Impact of a recombinant zoster vaccine on quality of life: data from a randomized, placebo controlled phase 3 trial in adult hematopoietic stem cell transplant recipients." IDWeek , California, United States Of America, pp.744, 2018

Curran, D. Et Al. (2018) . "Impact of a recombinant zoster vaccine on quality of life: data from a randomized, placebo controlled phase 3 trial in adult hematopoietic stem cell transplant recipients." IDWeek , California, United States Of America, p.744.

@conferencepaper{conferencepaper, author={D Curran Et Al. }, title={Impact of a recombinant zoster vaccine on quality of life: data from a randomized, placebo controlled phase 3 trial in adult hematopoietic stem cell transplant recipients}, congress name={IDWeek}, city={California}, country={United States Of America}, year={2018}, pages={744} }